Published in J Gen Microbiol on December 01, 1989
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature (2012) 5.63
characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2004) 3.28
Taurine reduction in anaerobic respiration of Bilophila wadsworthia RZATAU. Appl Environ Microbiol (1997) 1.78
Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol (2012) 1.26
Susceptibility testing of anaerobic bacteria: myth, magic, or method? Clin Microbiol Rev (1991) 1.25
Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination. Antimicrob Agents Chemother (1992) 1.25
Bilophila wadsworthia isolates from clinical specimens. J Clin Microbiol (1992) 1.21
Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS One (2013) 1.12
Dissimilatory sulfite reductase (desulfoviridin) of the taurine-degrading, non-sulfate-reducing bacterium Bilophila wadsworthia RZATAU contains a fused DsrB-DsrD subunit. J Bacteriol (2001) 1.11
A member of the delta subgroup of proteobacteria from a pyogenic liver abscess is a typical sulfate reducer of the genus Desulfovibrio. J Clin Microbiol (2001) 0.91
Bilophila wadsworthia bacteremia in two patients with hepatic abscesses. J Clin Microbiol (1992) 0.91
Culture-independent evaluation of the appendix and rectum microbiomes in children with and without appendicitis. PLoS One (2014) 0.85
Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected]. JPEN J Parenter Enteral Nutr (2013) 0.83
Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases. Dig Dis (2015) 0.82
Morphological response of Bilophila wadsworthia to imipenem: correlation with properties of penicillin-binding proteins. Antimicrob Agents Chemother (1993) 0.80
Preliminary study using species-specific oligonucleotide probe for rRNA of Bilophila wadsworthia. J Clin Microbiol (1994) 0.80
Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients. Front Pharmacol (2017) 0.76
Antimicrobial susceptibility testing of Bilophila wadsworthia isolates submitted for routine laboratory examination. J Clin Microbiol (1998) 0.75
Comparison of effects of medium composition and atmospheric conditions on detection of Bilophila wadsworthia beta-lactamase by cefinase and cefinase plus methods. J Clin Microbiol (2000) 0.75
Sydney M. Finegold. J Clin Microbiol (2012) 0.75
Consumption of a diet rich in Brassica vegetables is associated with a reduced abundance of sulphate-reducing bacteria: A randomised crossover study. Mol Nutr Food Res (2017) 0.75
Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts. Front Med (Lausanne) (2017) 0.75
Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol (1979) 12.54
Rapid diagnosis of bacteremia. Appl Microbiol (1969) 11.82
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. Appl Microbiol (1971) 6.99
High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother (1986) 6.34
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline. Appl Microbiol (1972) 6.17
Bacteremia after genitourinary tract manipulation: bacteriological aspects and evaluation of various blood culture systems. Appl Microbiol (1972) 6.04
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67
Rapid diagnosis of bacteremia with quantitative differential-membrane filtration culture. JAMA (1966) 5.66
Practical aerobic membrane filtration blood culture technique: clinical blood culture trial. J Clin Microbiol (1975) 4.80
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. J Infect Dis (1972) 4.62
Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr (1974) 4.58
Legionnaires' disease: clinical features of 24 cases. Ann Intern Med (1978) 4.30
Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis (1975) 4.16
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97
Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis (1980) 3.95
Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology (2000) 3.94
Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens. J Clin Microbiol (1979) 3.86
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Evaluation of polyanethol sulfonate (liquoid) in blood cultures. Antimicrob Agents Chemother (Bethesda) (1967) 3.80
Comparison of three procedures for biochemical testing of anaerobic bacteria. J Clin Microbiol (1975) 3.75
Whole chromosomal DNA probes for rapid identification of Mycobacterium tuberculosis and Mycobacterium avium complex. J Clin Microbiol (1987) 3.70
Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother (1985) 3.66
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med (1972) 3.62
Susceptibility of Bacteroides fragilis to six antibiotics determined by standardized antimicrobial disc susceptibility testing. Antimicrob Agents Chemother (1973) 3.47
Comparison of methods for isolation of anaerobic bacteria from clinical specimens. Appl Microbiol (1973) 3.30
Anaerobic pleuropulmonary infections. Medicine (Baltimore) (1972) 3.30
Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29
Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst (1966) 3.17
Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob Agents Chemother (1986) 3.08
Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med (1972) 3.05
Nomenclature for new tetracycline resistance determinants. Antimicrob Agents Chemother (1999) 2.89
Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) (1980) 2.81
Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them. J Infect Dis (1980) 2.76
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1981) 2.71
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Purification and characterization of Clostridium difficile toxin. Infect Immun (1979) 2.71
Illness in the Chronic Disease Family. Am J Public Health Nations Health (1942) 2.70
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66
Effect of a partially chemically defined diet on normal human fecal flora. Am J Clin Nutr (1972) 2.62
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol (1982) 2.52
Comparison of selective media for isolation of presumptive group D streptococci from human feces. Appl Microbiol (1971) 2.52
Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol (2000) 2.50
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Nomenclature for tetracycline resistance determinants. Antimicrob Agents Chemother (1989) 2.46
Legionnaires' disease: unusual clinical and laboratory features. Ann Intern Med (1980) 2.46
Anaerobic infections of the lung and pleural space. Am Rev Respir Dis (1974) 2.46
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45
Combined screw-cap and rubber-stopper closure for Hungate tubes (pre-reduced anaerobically sterilized roll tubes and liquid media). Appl Microbiol (1969) 2.44
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics. Antimicrob Agents Chemother (1972) 2.42
Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species. Rev Infect Dis (1981) 2.38
Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera. Rev Infect Dis (1981) 2.27
Cephalothin in serious bacterial infection. Ann Intern Med (1966) 2.25
Antimicrobial resistance in Bacteroides. J Antimicrob Chemother (1987) 2.23
Rapid method that aids in distinguishing Gram-positive from Gram-negative anaerobic bacteria. J Clin Microbiol (1981) 2.22
Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21
Isolation of a new serotype of legionnaires' disease bacterium. Lancet (1978) 2.21
Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother (1975) 2.21
Practical aerobic membrane filtration blood culture technique: development of procedure. J Clin Microbiol (1975) 2.20
Therapy for infections due to anaerobic bacteria: an overview. J Infect Dis (1977) 2.14
Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. Antimicrob Agents Chemother (1976) 2.12
High-level tetracycline resistance resulting from TetM in strains of Neisseria spp., Kingella denitrificans, and Eikenella corrodens. Antimicrob Agents Chemother (1988) 2.11
In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother (1999) 2.10
Joint infection by anaerobic bacteria: a case report and review of the literature. Arthritis Rheum (1969) 2.09
Uncommonly encountered, motile, anaerobic gram-negative bacilli associated with infection. Rev Infect Dis (1988) 2.09
Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07
The bacteriology of gangrenous and perforated appendicitis--revisited. Ann Surg (1990) 2.05
A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother (1999) 2.04
Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother (1989) 2.03
A microbiological comparison between acute and complicated appendicitis. Clin Infect Dis (1992) 2.02
Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother (1986) 2.01
Bacteriology of empyema. Lancet (1974) 2.00
Isolation of Legionella pneumophila from blood. Lancet (1979) 1.97
Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95
Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J Clin Microbiol (1992) 1.91
Infections due to anaerobes. Med Times (1968) 1.86
Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis. Lancet (1988) 1.86
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae. Gastroenterology (1980) 1.84
Conjugal transfer of transposon Tn916 from Streptococcus faecalis to Mycoplasma hominis. J Bacteriol (1987) 1.84
A miniature anaerobic jar for tissue transport or for cultivation of anaerobes. Am J Clin Pathol (1970) 1.79
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother (1985) 1.77
Diarrhea and colitis associated with antimicrobial therapy in man and animals. Am J Clin Nutr (1979) 1.76
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob Agents Chemother (1996) 1.76
Nitrocellulose filter blots for species identification of Mobiluncus curtisii and Mobiluncus mulieris. J Clin Microbiol (1984) 1.75
Legionnaires' disease in renal-transplant recipients. Lancet (1978) 1.75
Isolation of Legionella pneumophila from a transtracheal aspirate. J Clin Microbiol (1979) 1.74
A simple, rapid method to process and assay fatty acids and alcohols by gas chromatography. Anal Biochem (1973) 1.74
Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis (1981) 1.73
Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin. Antimicrob Agents Chemother (1981) 1.73
Haemophilus aphrophilus infections: clinical and bacteriologic studies. Ann N Y Acad Sci (1970) 1.73
Cell-wall-defective variants of Fusobacterium. Antimicrob Agents Chemother (1989) 1.73
Bone infections involving anaerobic bacteria. Medicine (Baltimore) (1978) 1.71
Clinical aspects of bacteremia after manipulation of the genitourinary tract. J Infect Dis (1973) 1.70